Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.
Engelberts PJ, Voorhorst M, Schuurman J, van Meerten T, Bakker JM, Vink T, Mackus WJ, Breij EC, Derer S, Valerius T, van de Winkel JG, Parren PW, Beurskens FJ.
Engelberts PJ, et al. Among authors: beurskens fj.
J Immunol. 2016 Dec 15;197(12):4829-4837. doi: 10.4049/jimmunol.1600811. Epub 2016 Nov 2.
J Immunol. 2016.
PMID: 27807190